CIBC Private Wealth Group’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-226
Closed -$4.85K 3402
2025
Q3
$4.85K Buy
+226
New +$5.07K ﹤0.01% 2571
2018
Q3
Sell
-10,000
Closed -$250K 1017
2018
Q2
$250K Hold
10,000
﹤0.01% 884
2018
Q1
$299K Hold
10,000
﹤0.01% 861
2017
Q4
$321K Hold
10,000
﹤0.01% 858
2017
Q3
$298K Hold
10,000
﹤0.01% 843
2017
Q2
$233K Hold
10,000
﹤0.01% 591
2017
Q1
$219K Hold
10,000
﹤0.01% 572
2016
Q4
$226K Hold
10,000
﹤0.01% 571
2016
Q3
$229K Hold
10,000
﹤0.01% 572
2016
Q2
$214K Buy
+10,000
New +$315K ﹤0.01% 580

Other funds holding ATEX

CIBC Private Wealth Group's ATEX Position: Q4 2025 in Review

CIBC Private Wealth Group sold out of Anterix (ATEX) in Q4 2025, closing a stake of 226 shares — an estimated $4.85K sold.

CIBC Private Wealth Group first reported a position in ATEX in Q2 2016 and held it in 10 quarters. The position peaked at $321K in Q4 2017. 117 funds tracked by Wall St. Rank hold ATEX as of Q4 2025.

  • CIBC Private Wealth Group reported no remaining Anterix position as of Q4 2025 after selling out during the quarter.
  • CIBC Private Wealth Group sold 226 Anterix shares in Q4 2025, an estimated $4.85K.
  • CIBC Private Wealth Group first reported a position in Anterix in Q2 2016 and held it in 10 quarters.
  • CIBC Private Wealth Group's Anterix position peaked at $321K in Q4 2017.
  • 117 funds tracked by Wall St. Rank held Anterix as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.